Profile
Pascal Breton is the founder and former Chairman & CEO of VitamFero SA, which was founded in 2005.
He is also the founder of Virsol Groupe.
Dr. Breton's former positions include Chairman of Laboratoires UPSA SAS, Director of ConjuChem, Inc., Director of BioArtificial Gel Technologies, Inc., Director-Biotech Investment of Halisol Group BV, Director of Rimon Therapeutics Ltd., Director-Business Development of IDM Pharma SAS, Director of Aarmedis Corp., Manager-Key Account & Global Business Development of SGS SA, and Principal of National Institute of Health Policy.
Dr. Breton received a doctorate degree from Université d'Orléans in 1989.
Former positions of Pascal Breton
| Companies | Position | End |
|---|---|---|
IDM Pharma SAS | Corporate Officer/Principal | - |
| SGS SA | Corporate Officer/Principal | - |
BioArtificial Gel Technologies, Inc.
BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director/Board Member | - |
Aarmedis Corp. | Director/Board Member | - |
ConjuChem, Inc.
ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs or pharmaceutical substances to treat Type 2 diabetes or other diagnostic substances | Director/Board Member | - |
Training of Pascal Breton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 12 |
|---|---|
ConjuChem, Inc.
ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs or pharmaceutical substances to treat Type 2 diabetes or other diagnostic substances | Health Technology |
SGS SA
SGS SA Miscellaneous Commercial ServicesCommercial Services Provides testing, inspection and certification services | Commercial Services |
Université d'Orléans
Université d'Orléans Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioArtificial Gel Technologies, Inc.
BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
National Institute of Health Policy | |
Halisol Group BV
Halisol Group BV Financial ConglomeratesFinance Function as investment holding company | Finance |
Rimon Therapeutics Ltd.
Rimon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medical polymers which helps to treat chronic wounds | Health Technology |
IDM Pharma SAS | |
VitamFero SA
VitamFero SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and vaccines | Health Technology |
Laboratoires UPSA SAS | |
Virsol Groupe | |
Aarmedis Corp. |
- Stock Market
- Insiders
- Pascal Breton
















